| Tag | Content |
|---|
EnhancerAtlas ID | HS134-29939 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr2:62389240-62390930 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| JUN | MA0488.1 | chr2:62390300-62390313 | ATGACCTCATCTA | - | 6.15 | | JUND(var.2) | MA0492.1 | chr2:62390299-62390314 | CATGACCTCATCTAA | - | 6.13 | | NFAT5 | MA0606.1 | chr2:62390628-62390638 | AATGGAAAAT | - | 6.02 | | NFATC1 | MA0624.1 | chr2:62390628-62390638 | AATGGAAAAT | - | 6.02 | | NFATC3 | MA0625.1 | chr2:62390628-62390638 | AATGGAAAAT | - | 6.02 | | Nkx3-2 | MA0122.3 | chr2:62390574-62390587 | TTTAAGTGGATAA | - | 6.14 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_50048 | chr2:62390423-62392234 | RPMI-8402 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I062163 | chr2 | 62390424 | 62392234 |
|
Enhancer Sequence | TCCTACCCTG AACATTGCCT CTTCCCTGAG GGGCTGGGCT TAAAGCGCTA CAGCATCTGA 60
GTACTAATGG GCACTTAAGC ATTAGGAAAA GATGATAGGG CAGCAGCTAG GAAGTCAGGC 120
AGCAGCATTA ACATGGCCCA GGAAGTCAGT GGCTTGGGAG ATCTGGTCCC GGTTTGAGGC 180
AGCCCTGTCA CAGCACTGGA ATAAACCACA ATCACAGAAG TTAAAGAACT CAAAGGGACA 240
TTTCACATGT GACGTTTTGT TACTGTGTTT CCCTCAAAAA TGGTAGTAGT ATGGCCATTT 300
CCAGAGGCTG AACAGCTGAA GGGATGACTG CATGCTAGAA TATCTCTACC TGCAACTAGC 360
CAAGGCTTTT CAGAGCTGCA TCGCCACCTT ACCTGGTGAA TATGCCTCTC CCAACTCTGC 420
ATAGTGGGCC TATGCAGGGT TTCTGTGGCC TCCAAGGAGA TGGTAACCAC AGAGGGAATC 480
TTGGCTCTTC CAAAAGGCCT TCGCATAGGA AGTCGAAGCT TTCACCCACC ATTAGATAGA 540
TGTATGTGTC ATGACAGGCC TTGGGTGGGT AGAGGGGGGC ACTGGTCAGG AACCCCTGAA 600
TCCTTTATTT CTGCAAATTT CCAGAAGGTC TAAGAATAGT ATCCTGCTCA GAGAAGGCAC 660
TCAACAATTT TCAGCAAATA TTTGAGTCTC TACTATGTTC CAGGAATTGT ATGAGGACAC 720
AGTAGTAGAC AAGAGAGACA AGGCCCCTAC CCTCAGATAG CATATATTAA CAGGAGTACC 780
TCAATATATA TTTATTCATC AGTTGATTTA GCTGTCTCAG CTCTTAGTGG CTTAAACTGC 840
ATTTATTTAT TTATTTATTT ATTTTAGTTC TGGAGTCTGG GAAATCCAAG ATCAAGGTGC 900
CAGCTGATTT AATTCCTGGT GAAGGCTCTC TTTCTGGTTT GCAGACAGTG GCTTTCTCAC 960
TGTGTCCTCA CATGGCAGAG AGGGAGAGGG AAAGAGAGAG ATCTGACTTC TCTTCTTCTT 1020
CTTATAAGGA CACTAATCCC ATTAGGAGGG CTTCACCCTC ATGACCTCAT CTAAATCTAA 1080
TTACCTCCCA AGGTGCTGCC TCCAAATACC AGCACATTGG GGGTTGGGGC TTCAACATAT 1140
GAATTTAGGG GGAGGGACAC AATTTAGCCA TAGCACTGGC TTTATCACAT CTTTGCAAGT 1200
TGTCTTCAGA ATGTTTTTGA GATGAATAAT GTTTGTGTGT GGGAGTAACA GAAGAGCCAT 1260
CTGTATTGTT TTCTAGAAGG GGTGATAGCT ATCAACTGGA GTCTTAAGAC TACTGGAAAA 1320
TCCTTCTTAA GATGTTTAAG TGGATAAGCC ACTAAGAGCT TAGTAATTGA GAAGCAAGGA 1380
AACAGTGAAA TGGAAAATAC GGGAGTATAA ATTGAACTTT GAAGACATCA TATTAGAGAA 1440
GTCAGAAGAC GGCTTTCTAA AAGAGTGTTG TTGCATTTGA GTAATAGAAG CTAAGAGCCA 1500
GGCATGGTGG TGCACCCTGT AGTCCCAGGA GACTGGGCTT AAGGGATCTC CCAGGGGGCT 1560
GCAGTGAGCT ATGATCATGC CACTACTCCC CAGCCTGAGT GACACAGCAA GACCCTCTCT 1620
CTCTTGCTCT CTTTTCTTTT ATTTTTAATA AGAAAGCTAA GCATATTCTT TAAAGTACGA 1680
TCATTGCAGA 1690
|
